SPIMACO

🌟 #CAD by #SPIMACO 🌟 We are thrilled to announce one of our standout investments in the pharmaceutical industry— CAD Middle East Pharmaceutical Industries LLC. As the only API (Active Pharmaceutical Ingredient) manufacturer in the #MiddleEast, CAD Middle East plays a pivotal role in strengthening the regional healthcare #SupplyChain and ensuring the availability of high-quality, locally-produced medicines. 🏭 About CAD Middle East: With state-of-the-art facilities and cutting-edge technology, CAD Middle East manufactures a wide range of APIs, contributing to the growth and self-sufficiency of the #pharmaceutical sector across #MENA. The company’s commitment to #innovation, #quality, and #sustainability sets it apart as a true leader in the industry. 📊 What’s Next? This investment reflects our strong belief in the growing pharmaceutical landscape and our dedication to enhancing local production capabilities in the Middle East. CAD Middle East is not only creating jobs but is also contributing to better #healthcare access for the community. 🔍 Explore CAD's Facility & Departments: Attached is a design that highlights CAD Middle East’s world-class facility and its various departments, showcasing the meticulous operations that drive the success of this incredible organization. At SPIMACO, we’re proud to support businesses that drive innovation and improve lives, both regionally and globally. 🌍💊

🚀 Celebrating R&D Excellence at SPIMACO – A Year of Achievements! 🚀 As we reflect on 2024, we are incredibly proud of the remarkable strides made by our Research & Development (R&D) team at #SPIMACO. Their dedication, innovation, and unwavering commitment to advancing healthcare have driven our success this year. It reflects the passion and expertise of our team, as well as SPIMACO’s ongoing commitment to delivering the highest quality #healthcare products to the market. As we look ahead to 2025, we are excited about the new projects and partnerships on the horizon, ensuring that SPIMACO continues to lead with innovation and excellence in every step we take. Here’s to another year of breakthroughs, growth, and making a positive impact on global health! 🌍💡

🌟 Reflecting on 4 months of team engagement at SPIMACO! 🌟 As we wrapped up our 2024 team engagement activities across our facilities in #SaudiArabia, we’re filled with pride and gratitude for the incredible connections we've made. Over the past few months, our staff has come together to strengthen bonds, foster collaboration, and celebrate the vibrant culture that makes #SPIMACO such a special place to work. These activities have not only enhanced teamwork but also showcased the power of unity and shared purpose. Together, we’ve built a more connected, supportive, and dynamic work environment that reflects our values and commitment to growth. But we’re just getting started! 🌱 The momentum of 2024 will continue to fuel us in 2025, with even more exciting initiatives to strengthen our culture and inspire greatness across our teams.

🌟 Join SPIMACO Team in 2025! 🌟 We’re excited to announce that #SPIMACO is expanding in 2025 and we’re looking for talented individuals to join our growing team! 🚀 We’re hiring for a variety of positions across different departments, offering exciting opportunities for growth and development within the pharmaceutical industry. Why join us? ✅ Competitive salary and benefits ✅ Opportunities for career growth and professional development ✅ A dynamic and innovative work environment ✅ Supportive and collaborative team culture If you're passionate, driven, and ready to make a difference, we want to hear from you! Ready to take the next step? Apply now and be part of our success story in 2025!

🌟 Spotlight on SPIMACO's R&D Department: Paving the Way for Regulatory Excellence 🌟 At #SPIMACO, our Research and Development (R&D) department plays a crucial role in the product registration process with the Saudi Food and Drug Authority (SFDA - هيئة الغذاء والدواء), ensuring that all our products meet the highest standards of safety, efficacy, and quality. The R&D team works diligently to develop innovative solutions, conduct comprehensive testing, and provide the necessary scientific data required for seamless regulatory approval. Their expertise is vital in navigating the complex regulatory landscape, ensuring timely registration, and bringing new, life-changing products to the market for the benefit of patients in #SaudiArabia. Together, we continue to build a healthier future for Saudi Arabia and beyond through #science, #innovation, and #dedication. 🚀

🌟 Proud Moment for #SPIMACO: A Milestone in #Biotechnology 🌟 We are thrilled to announce that SPIMACO has successfully produced Saudi Arabia’s first-ever biosimilar product fully manufactured within the Kingdom! 🇸🇦💉 This groundbreaking achievement marks a significant step forward in SPIMACO's commitment to driving #innovation and advancing the #pharmaceutical sector in #SaudiArabia. By producing #biosimilars locally, we not only contribute to enhancing #healthcare access but also play a key role in strengthening the local pharmaceutical industry. This milestone showcases our dedication to #quality, scientific excellence, and the #growth of the Saudi healthcare ecosystem. Together, we continue to shape a healthier future for Saudi Arabia and beyond! 🚀

🌟 SPIMACO Academy - "Beyond the Campus" Session: Phase Two 🌟 We are excited to announce the successful completion of the second phase of our #SPIMACO Academy - "Beyond the Campus" session! 🚀 Following the success of the first batch, which took place on November 26th, we welcomed another group of talented graduates and final-year pharmacy students from across #SaudiArabia. This session, held at our Riyadh HQ, continues to bridge the gap between academic learning and industry experience, offering participants real-world insights into the pharmaceutical sector. As part of SPIMACO’s ongoing #CSR efforts, this initiative is designed to empower the next generation of pharmaceutical professionals by providing them with the #knowledge, #skills, and confidence to succeed in the #industry. We are thrilled to have had students from top universities across the Kingdom, including: King Saud University Princess Nourah Bint Abdulrahman University Imam Abdulrahman Bin Faisal University Al Qasimia University Al Baha University King AbdulAziz University Al Yamamah University Prince Sattam bin Abdulaziz University University of Tabuk Shaqra University Umm Al-Qura University Al Maarefah University This marks an important step in our mission to shape the future of #healthcare by fostering local talent and contributing to the growth of the #pharmaceutical sector in Saudi Arabia. We are already looking forward to the third phase and the incredible impact it will have on our future healthcare leaders.

🌟 Spotlight on Dammam Pharma: Excellence in Manufacturing 🌟 At #SPIMACO, we are proud to have Dammam Pharma as one of our key subsidiaries, specializing in the manufacturing of oral tablets and capsules. 💊✨ With a focus on #quality, #innovation, and #reliability, #DammamPharma plays a crucial role in supporting our mission to provide high-quality healthcare solutions to the region. Their dedication to excellence is reflected in their #ISO and #GMP certifications, ensuring that every product meets the highest global standards. 🔗 Attached: ISO & GMP Certificates – a testament to Dammam Pharma's commitment to quality and compliance. We look forward to the continued success of Dammam Pharma as they help us drive forward our vision of #healthcare excellence in #SaudiArabia and beyond.

🌟 Exciting Announcement: SPIMACO and Organon Join Forces to Localize Products in Saudi Arabia 🌟 We are thrilled to share that #SPIMACO has officially signed a Memorandum of Understanding (MoU) with Organon during the #CPHI Middle East Exhibition to localize pharmaceutical products right here in #SaudiArabia! 🤝🇸🇦 This strategic partnership marks a significant milestone in our commitment to enhancing #healthcare access and expanding our local capabilities. Together, SPIMACO and #Organon aim to bring innovative and high-quality treatments to Saudi patients, empowering local manufacturing and driving healthcare advancements in the region. 🔗 Watch the video below to see highlights from the MoU signing ceremony, including a statement from Organon’s Country Lead, Mohamad Holayl, who shared their vision for this collaboration. We look forward to this promising journey ahead and the positive impact it will have on the healthcare sector in Saudi Arabia. 🚀

We are thrilled to share that #SPIMACO has signed a Memorandum of Understanding (MoU) with Boston Oncology Arabia, marking an exciting step forward in localizing oral oncology products and transferring technology and knowledge. This significant collaboration, announced during the #CPHI Middle East exhibition, aligns perfectly with #SaudiArabia's Vision 2030, which focuses on advancing local content development and boosting national industrial capabilities to ensure pharmaceutical security. In the attached video, a statement was made by SPIMACO's CEO, Jérôme Cabannes, and Boston Oncology Arabia's CEO, Abdullah Baaj, MD, PharmD. We look forward to the positive impact this partnership will have on the healthcare sector and the continued progress of the Kingdom’s pharmaceutical industry.